Real-world use of neratinib as extended adjuvant therapy in HER2-positive early-stage breast cancer: a multicentre study in mainland China and Hong Kong.

Nerlynx (neratinib) - Puma

Perjeta (pertuzumab) - Roche

Herceptin (trastuzumab) - Roche

http://www.ncbi.nlm.nih.gov/pubmed/42235181

Binghe Xu; Hai Hu; Haibo Wang; Hao Wang; Huanying Zhen; Kun Wang; Nilupai Abudureheiyimu; Qiang Liu; Ting Ying Ng; Wenlin Chen; Yanxia Shi; Yidong Zhou; Ying Fan; Yueran Jia; Zexi Peng; Zhao Liu; Zhuoqiong Ren; Ziyu Guo

Jun 4, 2026